It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...

chronic (long-term) respiratory disease, such as asthma (requires continuous or repeated use of inhaled or systemic steroids ...

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...

The leading cause for NHS staff absences was psychiatric illnesses, with 25.6% naming it as their reason for taking time off.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Pengana High Conviction Equities Fund portfolio manager James McDonald reckons these three biotechs are primed for growth.

The findings from influenza A virus and H5 subtype monitoring of wastewater have been published in the Sep. 19 issue of the U ...

The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...

The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Admi ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...